• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Dompe Farmaceutici`s Biologic Oxervate (cenegermin) Receives Approval in the U.S.

    FDA

    Eni and Dompe farmaceutici join forces for health research

    ECONOMIC TIMES

    Dompé farmaceutici Appoints Shannon K. Sullivan as CCO Biotech

    BUSINESSWIRE

    Dompe : New Published Data Point to Spike Protein Interactions with Estrogen

    PRNEWSWIRE

    Two Clinical Studies to Treat Mild-to-Moderate COVID-19 for Drug Design

    PRNEWSWIRE

    Dompé Announces Results of PII Study Evaluating Reparixin

    PRNEWSWIRE

    Dompé begins enrollment in Phase 3 of cenegermin in Sjögren`s-related DED

    PRNEWSWIRE

    Engitix Announces $54m Series A Financing & Strategic Collaboration

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.